Dare Bioscience
DARE
30 hedge funds and large institutions have $5.82M invested in Dare Bioscience in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.08% less ownership
Funds ownership: 0.77% → 0.69% (-0.08%)
3% less funds holding
Funds holding: 31 → 30 (-1)
55% less capital invested
Capital invested by funds: $12.8M → $5.82M (-$7.01M)
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$46.6K |
| 2 |
Jane Street
New York
|
+$20.6K |
| 3 |
VF
Virtu Financial
New York
|
+$8.6K |
| 4 |
BlackRock
New York
|
+$7.47K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.75K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Soviero Asset Management
New York
|
-$298K |
| 2 |
FFS
Founders Financial Securities
Towson,
Maryland
|
-$218K |
| 3 |
Renaissance Technologies
New York
|
-$139K |
| 4 |
Millennium Management
New York
|
-$48.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$26.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IA
26
IFS Advisors
Overland Park,
Kansas
| $9.46K | – | – | – |
|
27
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $3.65K | – | – | – |
|
28
Wells Fargo
San Francisco,
California
| $480 | -$9.3K | -832 | -95% |
|
|
RAM
29
Riggs Asset Management
Dallas,
Pennsylvania
| $208 | +$235 | +21 | New |
|
30
Bank of America
Charlotte,
North Carolina
| $166 | +$190 | +17 | New |
|
31
CIBC Private Wealth Group
Atlanta,
Georgia
| – | -$25K | -2,083 | Closed |
|
|
HF
32
HRT Financial
New York
| – | -$13K | -1,147 | Closed |
|
DARE Hedge Fund Activity: Q4 2022 in Review
30 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2022, worth a combined $5.82M — down 55% from $12.8M a quarter earlier.
Fund positioning in DARE was balanced in Q4 2022: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 11 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $46.6K. The largest seller was Soviero Asset Management, cutting an estimated $298K.
- 30 institutional investors held Dare Bioscience (DARE) as of Q4 2022, down from 31 in Q3 2022.
- Funds reported $5.82M of Dare Bioscience stock for Q4 2022, down 55% quarter-over-quarter.
- 3 funds opened new Dare Bioscience positions in Q4 2022 and 3 closed out, a net change of 0 holders.
- The largest Dare Bioscience buyer in Q4 2022 was Morgan Stanley, an estimated $46.6K added.
- The largest Dare Bioscience seller in Q4 2022 was Soviero Asset Management, an estimated $298K sold.
Based on aggregated 13F filings for Q4 2022.